These findings suggest a possible relationship between elevated SGLT1 and new-onset diabetes in COVID-19 patients and may help to explain why individuals with pro-inflammatory diseases, like diabetes and obesity, are more likely to develop severe COVID-19, which we propose occurs via a gut-mediated mechanism. The gene discussed is SLC5A1; the disease is COVID-19.